| scholarly article | Q13442814 |
| P2093 | author name string | Manuel F Casanova | |
| Latha K Parthasarathy | |||
| Ranga N Parthasarathy | |||
| Ratnam S Seelan | |||
| Jaganathan Lakshmanan | |||
| John I Stagner | |||
| Muthusamy Thangavel | |||
| Rifaat Shody El-Mallakh | |||
| Robert E Vadnal | |||
| P2860 | cites work | Calbindin D28k targets myo-inositol monophosphatase in spines and dendrites of cerebellar Purkinje neurons | Q24555720 |
| Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder | Q24626017 | ||
| A molecular mechanism for the effect of lithium on development | Q24629067 | ||
| 14-3-3epsilon is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome | Q28178021 | ||
| Decreased expression of hippocampal cholinergic neurostimulating peptide precursor protein mRNA in the hippocampus in Alzheimer disease | Q28202319 | ||
| Neural and developmental actions of lithium: a unifying hypothesis | Q28254375 | ||
| The cholinergic hypothesis of geriatric memory dysfunction | Q28277644 | ||
| Prediction of the coding sequences of unidentified human genes. X. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro | Q28282164 | ||
| Reduction in rat phosphatidylethanolamine binding protein-1 (PEBP1) after chronic corticosterone treatment may be paralleled by cognitive impairment: a first study | Q28564751 | ||
| The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS | Q28570728 | ||
| DISC1 regulates the transport of the NUDEL/LIS1/14-3-3epsilon complex through kinesin-1 | Q28576213 | ||
| Focal adhesion kinase acts downstream of EphB receptors to maintain mature dendritic spines by regulating cofilin activity | Q28585169 | ||
| Epileptiform activity and cognitive deficits in SNAP-25(+/-) mice are normalized by antiepileptic drugs | Q28590796 | ||
| Genome-wide association of mood-incongruent psychotic bipolar disorder | Q29417016 | ||
| Genome-wide association study of Alzheimer's disease with psychotic symptoms | Q29417042 | ||
| Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells | Q29618245 | ||
| Increased LIS1 expression affects human and mouse brain development | Q30639738 | ||
| Myo-inositol monophosphatase is an activated target of calbindin D28k | Q30842869 | ||
| Downregulation of PEBP1 in rat brain cortex in hypoxia | Q33496464 | ||
| Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder | Q33573983 | ||
| Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity | Q33844558 | ||
| Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3. | Q33887879 | ||
| Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia | Q34102163 | ||
| A SNAP25 promoter variant is associated with early-onset bipolar disorder and a high expression level in brain | Q34117472 | ||
| A common mechanism of action for three mood-stabilizing drugs | Q34128871 | ||
| Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder | Q34185366 | ||
| Emotion processing and regulation in bipolar disorder: a review | Q34282755 | ||
| Enhanced Prefrontal Function With Pharmacotherapy on a Response Inhibition Task in Adolescent Bipolar Disorder | Q34367584 | ||
| Valproate alters dopamine signaling in association with induction of Par-4 protein expression | Q34429621 | ||
| Rare copy number variants in neuropsychiatric disorders: Specific phenotype or not? | Q47236320 | ||
| Expression analysis of actin-related genes as an underlying mechanism for mood disorders | Q48350214 | ||
| Presymptomatic alterations in energy metabolism and oxidative stress in the APP23 mouse model of Alzheimer disease | Q48525431 | ||
| Increased levels of SNAP-25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar I disorder | Q48616079 | ||
| Lithium decreases turnover of arachidonate in several brain phospholipids | Q48828317 | ||
| Temporal proteomic profile of memory consolidation in the rat hippocampal dentate gyrus | Q48834842 | ||
| The effects of neuropsychiatric drugs on glycogen synthase kinase-3 signaling | Q48837770 | ||
| Activation of the Wnt signaling pathway: a molecular mechanism for lithium action | Q48958687 | ||
| Preliminary evidence for association between schizophrenia and polymorphisms in the regulatory Regions of the ADRA2A, DRD3 and SNAP-25 Genes | Q49090131 | ||
| Polymorphisms and haplotypes in the YWHAE gene increase susceptibility to bipolar disorder in Chinese Han population. | Q50736393 | ||
| Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia. | Q50782335 | ||
| Evidence that putative ADHD low risk alleles at SNAP25 may increase the risk of schizophrenia. | Q53519355 | ||
| The anti-apoptotic protein PEA-15 is a tight binding inhibitor of ERK1 and ERK2, which blocks docking interactions at the D-recruitment site. | Q53734950 | ||
| Investigation of variation inSNAP-25 and ADHD and relationship to co-morbid major depressive disorder | Q57400150 | ||
| Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia | Q34461247 | ||
| Co-prescription of medication for bipolar disorder and diabetes mellitus: a nationwide population-based study with focus on gender differences | Q34491836 | ||
| The genetics of schizophrenia and bipolar disorder: dissecting psychosis | Q34555635 | ||
| PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers | Q34622380 | ||
| Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen | Q34757926 | ||
| Lithium and valproic acid: parallels and contrasts in diverse signaling contexts | Q35003901 | ||
| Interaction networks of lithium and valproate molecular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signaling | Q35100070 | ||
| The effects of chronic treatment with mood stabilizers on the rat hippocampal post-synaptic density proteome | Q35341956 | ||
| Calcium binding protein markers of GABA deficits in schizophrenia--postmortem studies and animal models | Q35796571 | ||
| Association of VSNL1 with schizophrenia, frontal cortical function, and biological significance for its gene product as a modulator of cAMP levels and neuronal morphology | Q35844211 | ||
| Chronic treatment with lithium or valproate modulates the expression of Homer1b/c and its related genes Shank and Inositol 1,4,5-trisphosphate receptor. | Q35992454 | ||
| Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. | Q36189837 | ||
| Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder | Q36400018 | ||
| Evidence for involvement of ERK, PI3K, and RSK in induction of Bcl-2 by valproate | Q37460388 | ||
| High frequencies of de novo CNVs in bipolar disorder and schizophrenia | Q37578876 | ||
| Structure-function studies for the panacea, valproic acid | Q37597406 | ||
| Two-dimensional genome scan identifies multiple genetic interactions in bipolar affective disorder. | Q37659510 | ||
| Hypothesis review: are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorder? | Q37944127 | ||
| Turning CALM into excitement: AP180 and CALM in endocytosis and disease | Q38013774 | ||
| Potential opposite roles of the extracellular signal-regulated kinase (ERK) pathway in autism spectrum and bipolar disorders | Q38033860 | ||
| Why are antiepileptic drugs used for nonepileptic conditions? | Q38059891 | ||
| Microarray gene expression profiling of mouse brain mRNA in a model of lithium treatment | Q38292593 | ||
| The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth | Q38299684 | ||
| Genetic and post-mortem mRNA analysis of the 14-3-3 genes that encode phosphoserine/threonine-binding regulatory proteins in schizophrenia and bipolar disorder. | Q38322859 | ||
| PtdIns(3,4,5)P(3) and inositol depletion as a cellular target of mood stabilizers | Q38375751 | ||
| Early effects of mood stabilizers on the Akt/GSK-3beta signaling pathway and on cell survival and proliferation | Q39851823 | ||
| Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain | Q40771649 | ||
| The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. | Q40970988 | ||
| Disturbances in acute phase plasma proteins during melancholia: additional evidence for the presence of an inflammatory process during that illness | Q41093474 | ||
| Raf kinase inhibitory protein is required for cerebellar long-term synaptic depression by mediating PKC-dependent MAPK activation. | Q42829822 | ||
| Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers | Q43594287 | ||
| Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity. | Q44264548 | ||
| Valproate decreases inositol biosynthesis | Q45171168 | ||
| Genome-wide searches for bipolar disorder genes | Q45817101 | ||
| Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha-synuclein. | Q45922508 | ||
| Polymorphic variants of genes encoding MTHFR, MTR, and MTHFD1 and the risk of depression in postmenopausal women in Poland. | Q46359516 | ||
| Paliperidone as a mood stabilizer: a pre-frontal cortex synaptoneurosomal proteomics comparison with lithium and valproic acid after chronic treatment reveals similarities in protein expression | Q46460865 | ||
| Par-4 links dopamine signaling and depression | Q46623964 | ||
| The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. | Q46958808 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 927-936 | |
| P577 | publication date | 2014-04-01 | |
| P1433 | published in | Journal of Neuroscience Research | Q6295654 |
| P1476 | title | Proteomic analysis of rat prefrontal cortex after chronic valproate treatment | |
| P478 | volume | 92 |
| Q39145749 | Proteomic analysis of the postsynaptic density implicates synaptic function and energy pathways in bipolar disorder | cites work | P2860 |
Search more.